EAM
BBNX

Evanson Asset Management’s Beta Bionics BBNX Stock Holding History

Evanson Asset Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Hold
31,272
– – 0.02% 245
2025
Q4 		$953K Sell
31,272
-2,500
-7% -$66.8K 0.05% 144
2025
Q3 		$671K Sell
33,772
-5,000
-13% -$87.9K 0.04% 175
2025
Q2 		$565K Hold
38,772
– – 0.04% 185
2025
Q1 		$475K Buy
+38,772
New +$723K 0.03% 182

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Evanson Asset Management's BBNX Position: Q1 2026 in Review

Evanson Asset Management held its Beta Bionics (BBNX) position steady in Q1 2026 at 31,272 shares worth $313K. The position accounts for 0.02% of the portfolio, ranked #245.

Evanson Asset Management first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $953K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Evanson Asset Management held 31,272 shares of Beta Bionics worth $313K as of Q1 2026.
  • Evanson Asset Management left its Beta Bionics share count unchanged in Q1 2026.
  • Beta Bionics made up 0.02% of Evanson Asset Management's portfolio in Q1 2026, its #245 holding.
  • Evanson Asset Management first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Evanson Asset Management's Beta Bionics position peaked at $953K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Evanson Asset Management's 13F filing for Q1 2026, filed 8 Apr 2026.